Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments
Wenrui Zhang, … , Jiayi Chen, Yingying Lin
Wenrui Zhang, … , Jiayi Chen, Yingying Lin
Published November 21, 2023
Citation Information: J Clin Invest. 2024;134(3):e173299. https://doi.org/10.1172/JCI173299.
View: Text | PDF
Research Article Oncology

AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments

  • Text
  • PDF
Abstract

Oxygen and nutrient deprivation are common features of solid tumors. Although abnormal alternative splicing (AS) has been found to be an important driving force in tumor pathogenesis and progression, the regulatory mechanisms of AS that underly the adaptation of cancer cells to harsh microenvironments remain unclear. Here, we found that hypoxia- and nutrient deprivation–induced asparagine endopeptidase (AEP) specifically cleaved DDX3X in a HIF1A-dependent manner. This cleavage yields truncated carboxyl-terminal DDX3X (tDDX3X-C), which translocates and aggregates in the nucleus. Unlike intact DDX3X, nuclear tDDX3X-C complexes with an array of splicing factors and induces AS events of many pre-mRNAs; for example, enhanced exon skipping (ES) in exon 2 of the classic tumor suppressor PRDM2 leads to a frameshift mutation of PRDM2. Intriguingly, the isoform ARRB1-Δexon 13 binds to glycolytic enzymes and regulates glycolysis. By utilizing in vitro assays, glioblastoma organoids, and animal models, we revealed that AEP/tDDX3X-C promoted tumor malignancy via these isoforms. More importantly, high AEP/tDDX3X-C/ARRB1-Δexon 13 in cancerous tissues was tightly associated with poor patient prognosis. Overall, our discovery of the effect of AEP-cleaved DDX3X switching on alternative RNA splicing events identifies a mechanism in which cancer cells adapt to oxygen and nutrient shortages and provides potential diagnostic and/or therapeutic targets.

Authors

Wenrui Zhang, Lu Cao, Jian Yang, Shuai Zhang, Jianyi Zhao, Zhonggang Shi, Keman Liao, Haiwei Wang, Binghong Chen, Zhongrun Qian, Haoping Xu, Linshi Wu, Hua Liu, Hongxiang Wang, Chunhui Ma, Yongming Qiu, Jianwei Ge, Jiayi Chen, Yingying Lin

×

Figure 3

tDDX3X-C aggregates in the nucleus due to the absence of the N-terminal NES, and nuclear DDX3X is positively associated with AEP in HGG.

Options: View larger image (or click on image) Download as PowerPoint
tDDX3X-C aggregates in the nucleus due to the absence of the N-terminal ...
(A) 2-dimensional structure diagram of DDX3X. (B and C) HEK293T cells were transfected with mCherry-DDX3X, mCherry-DDX3X mutant NES, mCherry-DDX3X ΔNES, mCherry-tDDX3X-C, and mCherry-NES-tDDX3X-C for 24 hours, fixed, counterstained with DAPI, and finally visualized by confocal microscopy. Representative images are shown. Scale bar: 10 μm. (D) HEK293T cells were transfected with mCherry-DDX3X and mCherry-NES-tDDX3X-C for 24 hours and then treated with LMB, an inhibitor of protein nuclear transport. The follow-up procedure was the same as before. Representative images are shown. Scale bar: 10 μm. (E) Schematic diagram of DDX3X and its series of mutants; the corresponding location shift is shown. (F) HEK293T cells transfected with mCherry-tDDX3X-C mutant NLS1 and 2. The follow-up procedure was the same as before. Representative images are shown. Scale bar: 10 μm. (G) HeLa cells transfected with mCherry-DDX3X-GFP were cotransfected with or without AEP for 24 hours, counterstained with DAPI and visualized by confocal microscopy. Representative images are shown. Scale bar: 10 μm. All images were processed by Leica Imaging System software. (H) Representative images of IHC staining of AEP and DDX3X in glioma tissue microarrays containing different WHO grades. Scale bars: 200 μm for overview; 50 μm for enlargement. (I) Scatter plots of the nuclear DDX3X-positive ratio in HGG and LGG. Quantitative analysis (H-index) of IHC results was performed by Aipathwell (Servicebio, Wuhan). (J) Correlation analysis of AEP expression with the nuclear DDX3X-positive ratio in 2 glioma tissue microarray. Data were plotted as the mean ± SEM. Statistical analysis was performed using an unpaired t test (I) and Spearman correlation test (J). ***P < 0.001. Data shown are representative of 3 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts